B
Bactiguard
Bactiguard develops and provides infection prevention solutions that reduce the risk of healthcare-associated infections
About Bactiguard
Bactiguard is a medical technology company specializing in infection prevention solutions. The company operates in the healthcare sector, targeting hospitals and healthcare providers globally. Bactiguard's core products include advanced disinfectants, wound care solutions, and medical devices such as urinary catheters and central venous catheters that incorporate infection prevention technology. The company also collaborates with partners like Musti Group to expand its product range, including wound care for pets. Bactiguard generates revenue through the sale of its products and licensing agreements. The company is committed to contributing to global health goals by reducing hospital-acquired infections and antimicrobial resistance.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2005
- Headquarters
- Botkyrka kommun, Sweden
- Listing
- IPO 2014
- Sector
- Health Tech & Medtech
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Union
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bactiguard on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bactiguard on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.